Literature DB >> 25939973

Paraneoplastic encephalopathy: an unusual presenting feature of bladder cancer metastasis.

Gita Thanarajasingam1, Margherita Milone2, Manish Kohli1.   

Abstract

A 73-year-old woman with a history of localised transitional cell cancer (TCC) of the bladder, resected 22 years prior, presented with tremor, gait unsteadiness and cognitive deficits. Basic neurological workup was negative and CT of the abdomen revealed recurrent TCC with a solitary pelvic metastasis. She was treated with surgical resection of her tumour and immunosuppression. Her symptoms resolved, and it was felt her presentation was consistent with paraneoplastic encephalopathy in the setting of bladder cancer metastasis. She has remained disease and symptom free over 5 years of follow-up. This case report reviews the mechanism, clinical features and treatment of paraneoplastic neurological syndromes, and discusses briefly the management of oligometastatic recurrent bladder cancer. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25939973      PMCID: PMC4434336          DOI: 10.1136/bcr-2014-208913

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

Review 1.  Paraneoplastic syndromes involving the nervous system.

Authors:  Robert B Darnell; Jerome B Posner
Journal:  N Engl J Med       Date:  2003-10-16       Impact factor: 91.245

2.  Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers.

Authors:  Bruno Giometto; Wolfgang Grisold; Roberta Vitaliani; Francesc Graus; Jérôme Honnorat; Guido Bertolini
Journal:  Arch Neurol       Date:  2010-03

3.  Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.

Authors:  Richard J Sylvester; Adrian P M van der Meijden; Willem Oosterlinck; J Alfred Witjes; Christian Bouffioux; Louis Denis; Donald W W Newling; Karlheinz Kurth
Journal:  Eur Urol       Date:  2006-01-17       Impact factor: 20.096

4.  Recommended diagnostic criteria for paraneoplastic neurological syndromes.

Authors:  F Graus; J Y Delattre; J C Antoine; J Dalmau; B Giometto; W Grisold; J Honnorat; P Sillevis Smitt; Ch Vedeler; J J G M Verschuuren; A Vincent; R Voltz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-08       Impact factor: 10.154

Review 5.  Paraneoplastic neurological syndromes: an update on diagnosis, pathogenesis, and therapy.

Authors:  Raymond Voltz
Journal:  Lancet Neurol       Date:  2002-09       Impact factor: 44.182

6.  Surgery for metastatic urothelial carcinoma with curative intent: the German experience (AUO AB 30/05).

Authors:  Jan Lehmann; Henrik Suttmann; Peter Albers; Björn Volkmer; Jürgen E Gschwend; Guido Fechner; Martin Spahn; Axel Heidenreich; Axel Odenthal; Christoph Seif; Nils Nürnberg; Christian Wülfing; Christoph Greb; Tilmann Kälble; Marc-Oliver Grimm; Claus Friedrich Fieseler; Susanne Krege; Margitta Retz; Heiner Schulte-Baukloh; Martin Gerber; Markus Hack; Jörn Kamradt; Michael Stöckle
Journal:  Eur Urol       Date:  2008-11-29       Impact factor: 20.096

Review 7.  Paraneoplastic disorders of the central and peripheral nervous systems.

Authors:  Adrien Didelot; Jérôme Honnorat
Journal:  Handb Clin Neurol       Date:  2014

8.  Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome.

Authors:  Sean J Pittock; Thomas J Kryzer; Vanda A Lennon
Journal:  Ann Neurol       Date:  2004-11       Impact factor: 10.422

Review 9.  Paraneoplastic syndromes in patients with urological malignancies.

Authors:  Emilio Sacco; Francesco Pinto; Francesco Sasso; Marco Racioppi; Gaetano Gulino; Andrea Volpe; Pierfrancesco Bassi
Journal:  Urol Int       Date:  2009-07-27       Impact factor: 2.089

10.  Neural autoantibody clusters aid diagnosis of cancer.

Authors:  Erika S Horta; Vanda A Lennon; Daniel H Lachance; Sarah M Jenkins; Carin Y Smith; Andrew McKeon; Christopher Klein; Sean J Pittock
Journal:  Clin Cancer Res       Date:  2014-05-15       Impact factor: 12.531

View more
  2 in total

1.  Paraneoplastic neurological syndromes associated with renal or bladder cancer: case series and PRISMA-IPD systematic review.

Authors:  Macarena Villagrán-García; Sergio Muñiz-Castrillo; Nicolás Lundahl Ciano-Petersen; Alberto Vogrig; Antonio Farina; Marine Villard; Dimitri Psimaras; Agusti Alentorn; David Gonçalves; Nicole Fabien; Véronique Rogemond; Bastien Joubert; Jérôme Honnorat
Journal:  J Neurol       Date:  2022-09-01       Impact factor: 6.682

Review 2.  An uncommon manifestation of paraneoplastic cerebellar degeneration in a patient with high grade urothelial, carcinoma with squamous differentiation: A case report and literature review.

Authors:  Yaofeng Zhu; Shouzhen Chen; Songyu Chen; Jing Song; Fan Chen; Hu Guo; Zhenhua Shang; Yong Wang; Changkuo Zhou; Benkang Shi
Journal:  BMC Cancer       Date:  2016-05-21       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.